Literature DB >> 4555654

Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection.

W Brumfitt, R Pursell.   

Abstract

In order to test their value in urinary infection a double-blind trial was carried out using ampicillin, cephalexin, trimethoprim-sulphamethoxazole (co-trimoxazole), and trimethoprim. Eighty-three courses of treatment were given to hospital patients, 149 to pregnant women, and 107 to patients with dysuria and frequency seen in domiciliary practice. Thus infections of varying severity in defined groups of patients caused by organisms with different antibiotic sensitivities were treated.Analysis of the overall results (339 courses) was compared with those from the individual groups and considerable variation in response was found. In domiciliary infections and bacteriuria in pregnancy trimethoprim alone proved to be at least as effective as the other three compounds and caused fewer than half the number of side effects. In the hospital patients co-trimoxazole was superior to trimethoprim.The overall results for ampicillin and cephalexin were similar although cephalexin proved to be inferior in treating symptomatic domiciliary infections.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555654      PMCID: PMC1788903          DOI: 10.1136/bmj.2.5815.673

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Trimethoprim-resistant coliforms.

Authors:  R W Lacey; D M Bruten; W A Gillespie; E L Lewis
Journal:  Lancet       Date:  1972-02-19       Impact factor: 79.321

Review 2.  Bacteriuria of pregnancy--a critical appraisal.

Authors:  C W Norden; E H Kass
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

3.  Laboratory control of antibiotic therapy in urinary tract infection.

Authors:  W Brumfitt; A Percival
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

4.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

5.  Trimethoprim--sulphamethoxazole: comparative study in urinary infection in hospital.

Authors:  D S Reeves; M C Faiers; R E Pursell; W Brumfitt
Journal:  Br Med J       Date:  1969-03-01
  5 in total
  38 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Editorial: Confusion amongst the cephalosporins.

Authors:  R Wise
Journal:  Can Med Assoc J       Date:  1976-07-03       Impact factor: 8.262

3.  Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination.

Authors:  D W Reid; G Caille; N R Kaufmann
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

Review 4.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

5.  Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.

Authors:  S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

7.  Single dose trimethoprim for urinary tract infection.

Authors:  T Nolan; L Lubitz; F Oberklaid
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

8.  Trimethoprim and co-trimoxazole in the treatment of acute urinary tract infections: patient compliance and efficacy.

Authors:  D A Andrewes; P J Chuter; M J Dawson; B W Eden; R M Moore; D S Freestone; C A Morris
Journal:  J R Coll Gen Pract       Date:  1981-05

9.  Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.

Authors:  A Iravani; G A Richard; H Baer; R Fennell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

10.  Comparative, double-blind, prospective, multicenter trial of temafloxacin versus trimethoprim-sulfamethoxazole in uncomplicated urinary tract infections in women.

Authors:  A Iravani
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.